Hims & Hers Health (HIMS)
(Delayed Data from NYSE)
$62.55 USD
-3.63 (-5.49%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $62.51 -0.04 (-0.06%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth F Momentum C VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
HIMS 62.55 -3.63(-5.49%)
Will HIMS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HIMS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HIMS
Hims & Hers Stock to Report Q2 Earnings: What's in the Cards?
Fulgent Genetics, Inc. (FLGT) Surpasses Q2 Earnings and Revenue Estimates
HIMS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare
Earnings Preview: Evolent Health (EVH) Q2 Earnings Expected to Decline
Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates
Other News for HIMS
HIMS Stock Faces Mixed Sentiment Ahead of Earnings Report
Option traders moderately bearish in Hims and Hers Health with shares down 5.67%
Hims & Hers Health Inc (HIMS) Faces Class Action Lawsuit Over Alleged Misconduct | HIMS ...
Hims & Hers Health Earnings Preview
EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank?